Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05581719
Title A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enlivex Therapeutics RDO Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.